Shuhei Shinoda

Ube, 7558505, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

High intrapancreatic fat deposition accelerates pancreatic ductal adenocarcinoma growth and metastasis with enrollment of FABP5 upregulation.

High intrapancreatic fat deposition accelerates pancreatic ductal adenocarcinoma growth and metastasis with enrollment of FABP5 upregulation.

Journal: Scientific reports
Published: October 18, 2025

Lumen-apposing metal stent for peripancreatic fluid collection contributes to early improvement of nutritional status: A multicenter retrospective study (YCR-P001).

Lumen-apposing metal stent for peripancreatic fluid collection contributes to early improvement of nutritional status: A multicenter retrospective study (YCR-P001).

Journal: Medicine
Published: October 05, 2025

Extracellular vesicle microRNAs from human bone marrow MSCs suppress fibrogenesis of hepatic stellate cells by downregulation of RhoA signaling.

Extracellular vesicle microRNAs from human bone marrow MSCs suppress fibrogenesis of hepatic stellate cells by downregulation of RhoA signaling.

Journal: Stem cells (Dayton, Ohio)
Published: August 21, 2025

A Novel Index Consisting of Age, CA19-9, and Methylated Somatostatin Is Useful for Diagnosing Early Pancreatic Cancer.

A Novel Index Consisting of Age, CA19-9, and Methylated Somatostatin Is Useful for Diagnosing Early Pancreatic Cancer.

Journal: Cancer medicine
Published: July 16, 2025

Inhibition of fatty acid binding protein suppresses pancreatic cancer progression and metastasis.

Inhibition of fatty acid binding protein suppresses pancreatic cancer progression and metastasis.

Journal: Scientific reports
Published: March 17, 2025

Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy.

Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy.

Journal: Journal of gastroenterology
Published: April 01, 2024

Retraction Note: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.

Retraction Note: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.

Journal: BMC cancer
Published: December 12, 2023

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.

Journal: BMC cancer
Published: June 23, 2023

Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model.

Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model.

Journal: Cancer science
Published: March 13, 2023

A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia.

A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia.

Journal: DEN open
Published: December 19, 2022

Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery.

Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery.

Journal: Biomedicines
Published: April 20, 2022

Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2.

Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2.

Journal: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Published: March 04, 2021
Showing 1-12 of 19

Last Updated: 09/26/2026